{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:42:43Z","timestamp":1787010163753,"version":"build-2736575974"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"16","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4,17]]},"abstract":"<jats:p>\n                    This study aimed to investigate the risk factors for postoperative complications following transurethral thulium laser enucleation of the prostate (ThuLEP) and provide references for reducing the occurrence of postoperative complications. A retrospective analysis was conducted on 103 patients with benign prostate hyperplasia who underwent ThuLEP from September 2020 to August 2022. Among them, 95 patients had complete clinical and follow-up data. Clinical data and follow-up information of the patients were collected. Univariate and multivariate logistic regression analyses were performed to identify the influencing factors of postoperative complications following ThuLEP. The incidence of postoperative complications following ThuLEP was 11.58% (11\/95), among which the rates of Grade I, II, and III complications were 3.16% (3\/95), 3.16% (3\/95), and 5.29% (5\/95), respectively. The prostate volume after ThuLEP was 96.11\u2005\u00b1\u200543.38\u2009ml in the uncomplication group and 139.71\u2005\u00b1\u200596.41\u2009ml in the complication group, and there was a statistically significant difference between the 2 groups (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.02). The prostate mass after ThuLEP was 46.99\u2005\u00b1\u200522.14\u2009ml in the uncomplication group and 70.25\u2005\u00b1\u200541.37\u2009ml in the complication group, and there was a statistically significant difference between the 2 groups (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.01). The postoperative catheter removal time after ThuLEP was 3\u2005\u00b1\u20051.04 days in the uncomplication group and 2\u2005\u00b1\u20051.49 days in the complication group, and there was a statistically significant difference between the 2 groups (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.02).Univariate and multivariate logistic regression analyses revealed that the postoperative catheter removal time (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.046) was an independent risk factor for Grade II-III complications after ThuLEP. Prostate volume and prostate mass are influencing factors for postoperative complications following ThuLEP. Postoperative catheter removal time is an independent risk factor for postoperative complications following ThuLEP.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000048446","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T14:02:21Z","timestamp":1776434541000},"page":"e48446","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Analysis of Clavien-Dindo classification and risk factors for complications after transurethral Thulium Laser enucleation of the prostate"],"prefix":"10.1097","volume":"105","author":[{"given":"Chao","family":"Zuo","sequence":"first","affiliation":[{"name":"Department of Urology, Peking University First Hospital, Beijing, China"},{"name":"Department of Urology, Peking University First Hospital - Miyun Hospital, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5944-017X","authenticated-orcid":false,"given":"Wenzhi","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Urology, Peking University First Hospital - Miyun Hospital, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yisen","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of Urology, Peking University First Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunlin","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Urology, Peking University First Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghua","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Urology, Peking University First Hospital - Miyun Hospital, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuebing","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of Urology, Peking University First Hospital - Miyun Hospital, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Urology, Peking University First Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260605","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.prnil.2023.01.002","article-title":"Update on the management of benign prostatic hyperplasia and the role of minimally invasive procedures.","volume":"11","author":"Franco","year":"2023","journal-title":"Prostate Int"},{"key":"R2-20260605","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1097\/JU.0000000000002183","article-title":"Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA GUIDELINE PART I-initial work-up and medical management.","volume":"206","author":"Lerner","year":"2021","journal-title":"J Urol"},{"key":"R3-20260605","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.urology.2008.03.057","article-title":"Prevalence and characteristics of lower urinary tract symptoms in men aged > or = 80 years.","volume":"72","author":"Parsons","year":"2008","journal-title":"Urology"},{"key":"R4-20260605","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.eururo.2012.02.033","article-title":"A systematic review and meta-analysis on the use of phosphodiesterase 5 inhibitors alone or in combination with alpha-blockers for lower urinary tract symptoms due to benign prostatic hyperplasia.","volume":"61","author":"Gacci","year":"2012","journal-title":"Eur Urol"},{"key":"R5-20260605","first-page":"699","article-title":"Short-term outcomes of water vapor therapy (Rez\u016bm) for BPH\/LUTS in the first czech cohort.","volume":"18","author":"Wasserbauer","year":"2021","journal-title":"Urol J"},{"key":"R6-20260605","doi-asserted-by":"crossref","first-page":"15330338231155000","DOI":"10.1177\/15330338231155000","article-title":"Minimally invasive treatment in benign prostatic hyperplasia (BPH).","volume":"22","author":"Sciacqua","year":"2023","journal-title":"Technol Cancer Res Treat"},{"key":"R7-20260605","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.eururo.2023.02.028","article-title":"Minimally invasive treatments for benign prostatic obstruction: a systematic review and network meta-analysis.","volume":"83","author":"Cornu","year":"2023","journal-title":"Eur Urol"},{"key":"R8-20260605","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00345-023-04308-z","article-title":"Peri- and post-operative outcomes, complications, and functional results amongst different modifications of endoscopic enucleation of the prostate (EEP): a systematic review and meta-analysis.","volume":"41","author":"Ortner","year":"2023","journal-title":"World J Urol"},{"key":"R9-20260605","first-page":"682","article-title":"Current use of thulium lasers in endourology and future perspectives.","volume":"73","author":"Netsch","year":"2020","journal-title":"Arch Esp Urol"},{"key":"R10-20260605","doi-asserted-by":"crossref","first-page":"l5919","DOI":"10.1136\/bmj.l5919","article-title":"Comparative efficacy and safety of new surgical treatments for benign prostatic hyperplasia: systematic review and network meta-analysis.","volume":"367","author":"Huang","year":"2019","journal-title":"BMJ"},{"key":"R11-20260605","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.euf.2021.03.024","article-title":"Holmium versus thulium laser enucleation of the prostate: a systematic review and meta-analysis of randomized controlled trials.","volume":"8","author":"Hartung","year":"2022","journal-title":"Eur Urol Focus"},{"key":"R12-20260605","doi-asserted-by":"crossref","first-page":"128001","DOI":"10.1117\/1.JBO.19.12.128001","article-title":"Thulium fiber laser lithotripsy in an in vitro ureter model.","volume":"19","author":"Hardy","year":"2014","journal-title":"J Biomed Opt"},{"key":"R13-20260605","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00345-009-0504-z","article-title":"Complications of laser prostatectomy: a review of recent data.","volume":"28","author":"Rieken","year":"2010","journal-title":"World J Urol"},{"key":"R14-20260605","first-page":"357","article-title":"Complications and functional outcomes of endoscopic enucleation of the prostate: a systematic review and meta-analysis of randomised-controlled studies.","volume":"75","author":"Pang","year":"2022","journal-title":"Cent Eur J Urol"},{"key":"R15-20260605","doi-asserted-by":"crossref","first-page":"461","DOI":"10.5152\/tud.2021.21170","article-title":"Current evidence of ThuLEP for BPH: a review of literature.","volume":"47","author":"Bozzini","year":"2021","journal-title":"Turk J Urol"},{"key":"R16-20260605","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/JU.0000000000001298","article-title":"Surgical management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline amendment 2020.","volume":"204","author":"Parsons","year":"2020","journal-title":"J Urol"},{"key":"R17-20260605","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.eururo.2013.03.004","article-title":"EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction.","volume":"64","author":"Oelke","year":"2013","journal-title":"Eur Urol"},{"key":"R18-20260605","first-page":"59","article-title":"Complications from normal saline in thulium laser enucleation of the prostate.","volume":"61","author":"Grass","year":"2022","journal-title":"Urologe A"},{"key":"R19-20260605","doi-asserted-by":"crossref","first-page":"6575","DOI":"10.1038\/s41598-018-25069-5","article-title":"Incidence and predictors of readmission within 30 days of transurethral resection of the prostate: a single center European experience.","volume":"8","author":"Palmisano","year":"2018","journal-title":"Sci Rep"},{"key":"R20-20260605","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.eururo.2011.10.009","article-title":"Laser treatment of benign prostatic obstruction: basics and physical differences.","volume":"61","author":"Bach","year":"2012","journal-title":"Eur Urol"},{"key":"R21-20260605","doi-asserted-by":"crossref","first-page":"e14523","DOI":"10.1111\/and.14523","article-title":"Urethral and bladder neck stenosis after thulium laser enucleation of the prostate: analysis of risk factors in a series of 1003 patients.","volume":"54","author":"Castellani","year":"2022","journal-title":"Andrologia"},{"key":"R22-20260605","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1177\/0391560318758195","article-title":"Risk factors for urethral stricture and\/or bladder neck contracture after monopolar transurethral resection of the prostate for benign prostatic hyperplasia.","volume":"85","author":"Grechenkov","year":"2018","journal-title":"Urologia"},{"key":"R23-20260605","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.urology.2020.09.038","article-title":"Catheter removal on the same day of holmium laser enucleation of the prostate: outcomes of a pilot study.","volume":"146","author":"Agarwal","year":"2020","journal-title":"Urology"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000048446","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T16:01:30Z","timestamp":1780675290000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000048446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":23,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048446","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"assertion":[{"value":"2024-04-27","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-06","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}